Invex Therapeutics Advances Exenatide Development

Invex Therapeutics Ltd. (AU:IXC) has released an update. Invex Therapeutics Ltd has concluded its Phase III IIH EVOLVE clinical trial and is now fo...#invextherapeuticsltd #ixc #phaseiiiiihevolve
Source: Reuters: Health - Category: Consumer Health News Source Type: news